Lastly, AP002761.4 and ZNF236-DT appear to affect the immune microenvironment and tumor growth in acute myeloid leukemia (AML) (Zhao et al., 2024) and pancreatic adenocarcinoma (Huang et al., 2023), respectively. Here, ZNF236 is linked to acute myeloid leukemia.